Dr. Hui Qin Wang

Founder & Senior Pharmacologist

PathForward Pharmacology Consulting is founded by Dr. Hui Qin Wang, a seasoned preclinical pharmacologist with deep expertise in oncology therapeutics—spanning small molecules, biologics, antibody–drug conjugates (ADCs), and immune cell engagers.

With over 20 years of experience at Novartis and EMD Serono, Dr. Wang has helped R&D teams make informed go/no-go decisions through robust integration of PK/PD, efficacy, and biomarker data. Her translational insight has supported critical decision points from discovery through early clinical development.

What sets her apart is her ability to combine cutting-edge translational models with strategic foresight—fostering collaboration, driving data-driven decisions, and bringing clarity to complex pharmacology challenges across oncology drug development.